Judo Bio

Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of oligonucleotide therapies intended to offer genetic medicines. Judo Bio is based in Cambridge, MA and was founded in 2021. Its last known valuation is $115 million. It has raised $105 million across 3 recorded rounds; the latest was a $25 million early-stage round in Jul 2024.

Last price · $/share
—
Implied valuation
$115.0M
Total raised
$105.0M
Last round
Early Stage VC
Jul 2024

Who backs Judo Bio?

7 investors
InvestorType
Alexandria Venture InvestmentsOther
Digitalis VenturesVenture capital
Euclidean CapitalFamily office
Atlas VentureOther
Droia Ventures—
The Column Group—
YK Bioventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Judo Bio investors

7 investors are on record for Judo Bio, including Alexandria Venture Investments, Digitalis Ventures, Euclidean Capital and Atlas Venture. The early-stage round in Jul 2024 drew 21 investors.

Free account
More of Judo Bio with a free account
  • ·Watch Judo Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Judo Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View